Pretreatment of leishmania homologue of receptors for activated C kinase (LACK) promotes disease progression caused by Leishmania amazonensis

Experimental Animals

Volumn 51, Issue 4, 2002, Pages 335-341

  Okuno, Takahiro ^a   Takeuchi, Makoto ^a   Matsumoto, Yoshitsugu ^a   Otsuka, Haruki ^a   Matsumoto, Yasunobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Leishmania amazonensis; Leishmania homologue of receptors for activated C kinase; Molecular cloning

Indexed keywords

LEISHMANIA AMAZONENSIS;

COMPLEMENTARY DNA; LACK ANTIGEN, LEISHMANIA; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DISEASE COURSE; GENETICS; IMMUNOLOGY; LEISHMANIA; MALE; MOLECULAR CLONING; MOUSE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CLONING, MOLECULAR; DISEASE PROGRESSION; DNA, COMPLEMENTARY; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS;

EID: 0036653614     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.51.335     Document Type: Article

References (39)

1. Afonso, L.C. and Scott, P. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 51: 2952-2959.
2. Baily, G. and Nandy, A. 1994. Visceral leishmaniasis: more prevalent and more problematic. J. Infect. 29: 241-247.
3. Barral, A., Petersen, E.A., Sacks, D.L., and Neva, F.A. 1983. Late metastatic leishmaniasis in the mouse: a model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32: 277-285.
4. Bradley, D.J. 1974. Genetic control of natural resistance to Leishmania donovani. Nature 250: 353-354.
5. Bradley, D.J. and Kirkley, J. 1977. Regulation of Leishmania population within the host. I. The variable course of Leishmania donovani infections in mice. Clin. Exp Immunol. 30: 119-129.
6. Bretscher, P.A., Wei, G., Menon, J.N., and Bielefeldt, O.H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257: 539-542.
7. Childs, G.E., Lightner, E.A., McKinney, L., Groves, M.G., Price, E.E., and Hendricks, L.D. 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann. Trop. Med. Parasitol. 78: 25-34.
8. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
9. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Rollinghoff, M., Gresser, I., and Bogdan, C. 1998. Typel interferon (IFN α/β) and type2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. 1998. Immunity 8: 77-87.
10. Gonzalez, A.G., Taladriz, S., Marquet, A., and Larraga, V. 1999. Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum. Eur. J. Biochem. 259: 909-916.
11. Grimaldi, G. Jr., Moriearty, P.L., and Hoff, R. 1980. Leishmania mexicana: immunology and histopathology in C3H mice. Exp. Parasitol. 50:45-56.
12. Haya, H., Pascal, L., Fabienne, T.C., and Jacques, A.L. 1999. Some of the early events underlying Th2 cell maturation and susceptibility to Leishmania major infection in BALB/c mice. Biol. Chem. 380: 909-914.
13. Herwaldt, B. 1999. Leishmaniasis. Lancet 354: 1191-1199.
14. Julia, V., Rassoulzadegan, M., and Glaichenhaus, N. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274: 421-423.
15. -. Eur. J. Immunol. 25: 3298-3307.
16. Launois, P., Ohteki, T., Swirhart, K., MacDonald, H.R., and Louis, J.A. 1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4 (+) T cells instructs the development and susceptibility to Leishmania major in BALB/c mice. Immunity 6: 541-549.
17. Launois, P., Kristin, G.S., Genevieve, M., and Jacques, A.L. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158: 3317-3324.
18. Launois, P., Tacchini-Cottier, F., Parra-Lopez, C., and Louis, J.A. 1998. Cytokine in parasitic diseases: the example of cutaneous leishmaniasis. Int. Rev. Immunol. 17: 157-180.
19. Luis, C.C.A., Tanya, M.S., Leda, Q.V., Maria, W., Giorgio, T., and Phillip, S. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 14: 235-237.
20. + T cells in Pathogenesis Associated with Leishmania amazonensis Infection. J. Immunol. 158: 5374-5383.
21. + T cells normally producing the early IL-4 instruction Th2 cell development and susceptibility to Leishmania major in BALB/c mice. Eur. J. Immunol. 31: 1288-1296.
22. Manuel, J. and Ransijin, A. 1997. Leishmania spp.: Mechanisms of toxicity of nitrogen oxidation products. Exp. Parasitol. 87: 98-111.
23. Mougneau, E., Altare, F., Wakil, A.E., Zheng, S., Coppola, T., Wang, Z.E., Waldmann, R., Locksley, R.M., and Glaichenhaust, N. 1995. Expression cloning of a protective Leishmania antigen. Science 268: 563-566.
24. Muller, I., Pedrazzini, T., Parrel, J.P., and Louis, J. 1989. T-cell responses and immunity to experimental infection with Leishmania major. Ann. Rev. Immunol. 7: 561-578.
25. Neal, R.A. and Hale, C. 1983. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniasis. Parasitol. 87: 7-13.
26. Nasseri, M. and Modabber, F.Z. 1979. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major. Infect. Immun. 26: 611-614.
27. Pascal, L., Fatima, C.S., Hayo, H., Carlos, P.L., Fabuene, T.C., and Jaques A.L. 1998. Setting in motion the immune mechanism underlying genetically determined resistance and susceptibility to infection with Leishmania major. Parasite Immunol. 20: 223-230.
28. Pearson, R.D. and deQueiroz S.A. 1996. A clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22: 1-13.
29. Reiner, S.L., Wang, Z.E., Hatam, F., Scott, P., and Locksley, R.M. 1993. Th1 and Th2 cell antigen receptors in experimental Leishmaniasis. Science 259: 1457-1460.
30. Reiner, S.L. and Locksley, R.M. 1995. The regulation of immunity to Leishmania major. Ann. Rev. Immunol. 13: 151-177.
31. Sanjay, G., Calmen, P., David L.S., and Robert, A.S. 1998. Vaccination requirement for cellular immunity to an intracellular parasitic infection. Nature Med. 4: 1409-1415.
32. Scott, P. A. and Ferrel, J.P. 1982. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am. J. Trop. Med. Hyg. 31: 230-238.
33. Stenger, S., Donhauser, N., Thurin, H., Rollinghoff, M., and Bogdan, C. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183: 1501-1514.
34. Stephen, J.M., Carola, R., Roxanne, P., Valerie, J., Cecil, C., and Nicol, G. 1998. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur. J. Immunol. 28: 424-432.
35. Taladriz, S., Gonzalez, A.G., Marquet, A., and Larraga, V. 1999. Cloning, molecular analysis and differential cell localization of the p36 RACK analogue antigen from the parasite protozoon Crithidia fasciculata. FEBS Letters 443: 375-380.
36. Thirteenth Program Report. 1997. Special program for Research and Training in Tropical Disease, leishmaniasis. Geneva: World Health Organization Publications. 100-111.
37. Titus, R., Theodoe, G., Kimsey, C.M., Shanker, P.B., Hall, A., McGurn, L.M., and Povielli, L. 1992. Roll of T cells in immunity of the intracellular pathogen Leishmania major. Subcell. Biochem. 18: 99-129.
38. Wei, Q., Charles, I.G., Smith, A., Feng, G.J., Hang, F.P., Xu, D., Muller, W., Moncada, S., and Liew, F.Y. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411.
39. Werner, S. and Tamas, L. 2000. The host response to Leishmania infection. Adv. Immunol. 74: 275-317.